Supernus Pharmaceuticals | SUPN - 税前利润

股票价格

50.68

每天变化

-0.82 -1.59%

每月一次

-4.77%

每年

60.03%

Q2 预测

49.30

金融业

USD

USD 1.45B

现金及等价物

USD 151.37M

USD 47.53M

USD 644.18M

USD 338.17M

USD 42.21M

USD 13.82M

USD 48.5M

674

EPS每股收益

USD -0.07

股本和储备

USD 1.06B

USD 164.04M

债务利息支出

USD 910K

USD 2.28M

USD 400.38M

USD 2.85B

USD -45.12M

USD 197.75M

USD 13.82M

普通股股本

USD 57.12M

110.38

USD -1.91M

USD 211.6M

销售和管理费用

USD 122.39M

USD 107.1M

贸易债权人

USD 107.8M

应收帐款人

USD 187.8M

	税前利润	更改		日
Abbott	USD 2.36B		178M	2025-12
ANI Pharmaceuticals	USD 49.52M		39M	2025-09
Aurora Cannabis	CAD -1.58M		48.55M	2025-12
Bristol-Myers Squibb	USD 3.11B		1.34B	2025-09
Canopy Growth	CAD -62.26M		60.84M	2025-12
Cara Therapeutics	USD -4.91M		3.17M	2025-03
Corcept Therapeutics	USD 15.24M		16.45M	2025-09
Eisai	JPY 22B		7.47B	2025-12
Eli Lilly	USD 7.23B		456M	2025-09
Novo Nordisk	DKK 33.8B		3.23B	2025-06
Pacira	USD 9.52M		11.45M	2025-09
Perrigo	USD 22.4M		19.2M	2025-09
Pfizer	USD 3.33B		290M	2025-09
Supernus Pharmaceuticals	USD -1.91M		56.04M	2025-12
United Therapeutics	USD 444M		6M	2025-12
Xeris Pharmaceuticals	USD 11.08M		10.46M	2025-12